Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma.
Liesche-Starnecker F, Mayer K, Kofler F, Baur S, Schmidt-Graf F, Kempter J, Prokop G, Pfarr N, Wei W, Gempt J, Combs SE, Zimmer C, Meyer B, Wiestler B, Schlegel J.
Liesche-Starnecker F, et al. Among authors: prokop g.
Cancers (Basel). 2020 Oct 13;12(10):2964. doi: 10.3390/cancers12102964.
Cancers (Basel). 2020.
PMID: 33066251
Free PMC article.